Von Vascular has announced the publication of a pivotal preclinical research study evaluating the performance of its Algo smart pump technology used in ‘smart static mode’. The study—which saw the Algo system achieve significantly higher rates of complete clot ingestion (CCI) as compared to a leading commercial aspiration pump in stroke thrombectomy procedures—has been published in Clinical Neurology and Neurosurgery.
The study assessed the efficacy of the Algo smart pump in mechanical thrombectomy for acute ischaemic stroke using a validated in-vitro flow model.
As claimed by Von Vascular in a recent press release, results not only demonstrated that the Algo pump’s smart static mode achieved significantly higher rates of CCI compared to a leading commercial aspiration pump, but were also achieved without increasing aspiration time—suggesting that Algo may offer both efficiency and enhanced performance benefits in neurointerventional procedures.
“This study reflects the growing need to evaluate and innovate aspiration technology in thrombectomy,” said Brian Jankowitz (Hackensack Meridian Health, Edison, USA), one of the study’s senior investigators. “The Algo smart pump showed consistent performance across a range of catheters and offers a compelling, modern alternative for clinicians focused on maximising clot removal during the first pass.”
Von Vascular’s release goes on to detail that the Algo smart pump is a compact, sterile, operator-controlled device designed to improve the precision and effectiveness of clot retrieval in stroke treatment. Its smart static aspiration technology is intended to dynamically adjust suction based on catheter feedback, offering a novel, data-driven approach to clot ingestion mechanics.
